Manulife (Manufacturers Life Insurance)’s Cabaletta Bio CABA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,011	Closed	-$28K	–	2822
2025 Q4	$28K	Sell	13,011 -73	-0.6%	-$181	﹤0.01%	2848
2025 Q3	$30.6K	Sell	13,084 -26,686	-67%	-$45.8K	﹤0.01%	2897
2025 Q2	$60.5K	Sell	39,770 -17,266	-30%	-$26.9K	﹤0.01%	2859
2025 Q1	$79K	Buy	57,036 +765	+1%	+$1.63K	﹤0.01%	2747
2024 Q4	$128K	Buy	56,271 +407	+0.7%	+$1.43K	﹤0.01%	2768
2024 Q3	$264K	Sell	55,864 -560	-1%	-$3.24K	﹤0.01%	2540
2024 Q2	$422K	Buy	56,424 +4,191	+8%	+$51.4K	﹤0.01%	2282
2024 Q1	$891K	Sell	52,233 -444	-0.8%	-$9.53K	﹤0.01%	1908
2023 Q4	$1.2M	Buy	52,677 +39,427	+298%	+$663K	﹤0.01%	1715
2023 Q3	$202K	Buy	13,250 +2,761	+26%	+$37.7K	﹤0.01%	2601
2023 Q2	$135K	Buy	+10,489	New	+$114K	﹤0.01%	2744

Other funds holding CABA

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CABA Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) sold out of Cabaletta Bio (CABA) in Q1 2026, closing a stake of 13,011 shares — an estimated $28K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CABA in Q2 2023 and held it in 11 quarters. The position peaked at $1.2M in Q4 2023. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

Manulife (Manufacturers Life Insurance) reported no remaining Cabaletta Bio position as of Q1 2026 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 13,011 Cabaletta Bio shares in Q1 2026, an estimated $28K.
Manulife (Manufacturers Life Insurance) first reported a position in Cabaletta Bio in Q2 2023 and held it in 11 quarters.
Manulife (Manufacturers Life Insurance)'s Cabaletta Bio position peaked at $1.2M in Q4 2023.
108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.